Tudor Investment Corp Portfolio holdings
AUM
$13.2B
1-Year Return
6.99%
This Quarter Return
-1.45%
1 Year Return
+6.99%
3 Year Return
+37.99%
5 Year Return
+86.9%
10 Year Return
+285.99%
AUM
$11.2B
AUM Growth
+$1.81B
(+19%)
Cap. Flow
+$2.15B
Cap. Flow
% of AUM
19.17%
Top 10 Holdings %
Top 10 Hldgs %
17.38%
Holding
2,302
New
520
Increased
510
Reduced
405
Closed
521
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
+$609M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$107M |
| 3 |
Walmart
WMT
|
+$85.4M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$82M |
| 5 |
Broadcom
AVGO
|
+$76.1M |
Top Sells
| 1 |
Energy Select Sector SPDR Fund
XLE
|
+$157M |
| 2 |
iShares Bitcoin Trust
IBIT
|
+$155M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$142M |
| 4 |
INFN
Infinera Corporation Common Stock
INFN
|
+$108M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.9M |
Sector Composition
| 1 | Technology | 15.93% |
| 2 | Financials | 11.61% |
| 3 | Healthcare | 10.24% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Industrials | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
801
Camden National
CAC
$683M
| $2.08M | 0.01% |
51,297
+20,153
| +65% | +$816K |
|
802
NovoCure
NVCR
$1.42B
| $2.07M | 0.01% |
+116,418
| New | +$2.07M |
|
803
Allison Transmission
ALSN
$7.57B
| $2.06M | 0.01% |
+21,583
| New | +$2.06M |
|
804
Protagonist Therapeutics
PTGX
$3.7B
| $2.06M | 0.01% |
+42,583
| New | +$2.06M |
|
805
Noble Corp
NE
$4.82B
| $2.06M | 0.01% |
+86,766
| New | +$2.06M |
|
|
SILA
806
Sila Realty Trust, Inc.
SILA
$1.39B
| $2.05M | 0.01% |
+76,784
| New | +$2.05M |
|
807
PTC Therapeutics
PTCT
$4.81B
| $2.04M | 0.01% |
40,112
-7,039
| -15% | -$359K |
|
808
Mizuho Financial
MFG
$82.3B
| $2.04M | 0.01% |
+370,242
| New | +$2.04M |
|
809
Fidelis Insurance
FIHL
$1.81B
| $2.04M | 0.01% |
125,825
-11,296
| -8% | -$183K |
|
810
Great Lakes Dredge & Dock
GLDD
$823M
| $2.03M | 0.01% |
233,685
+7,447
| +3% | +$64.8K |
|
811
Strategic Education
STRA
$1.99B
| $2.02M | 0.01% |
24,072
+9,110
| +61% | +$765K |
|
812
Axogen
AXGN
$776M
| $2.01M | 0.01% |
108,739
+21,188
| +24% | +$392K |
|
813
ServisFirst Bancshares
SFBS
$4.62B
| $2M | 0.01% |
+24,238
| New | +$2M |
|
814
Sunrun
RUN
$3.8B
| $2M | 0.01% |
+340,472
| New | +$2M |
|
815
Walker & Dunlop
WD
$2.97B
| $1.99M | 0.01% |
23,323
-28,785
| -55% | -$2.46M |
|
816
Baxter International
BAX
$12.5B
| $1.98M | 0.01% |
+57,944
| New | +$1.98M |
|
817
The Ensign Group
ENSG
$9.75B
| $1.98M | 0.01% |
15,303
+1,532
| +11% | +$198K |
|
818
Valmont Industries
VMI
$7.59B
| $1.97M | 0.01% |
6,916
-927
| -12% | -$265K |
|
819
SentinelOne
S
$6.21B
| $1.97M | 0.01% |
108,230
-15,120
| -12% | -$275K |
|
820
Blend Labs
BLND
$1.12B
| $1.95M | 0.01% |
582,121
+461,496
| +383% | +$1.55M |
|
|
BPMC
821
DELISTED
Blueprint Medicines
BPMC
| $1.95M | 0.01% |
22,011
+13,911
| +172% | +$1.23M |
|
822
Avery Dennison
AVY
$13.1B
| $1.93M | 0.01% |
10,839
-19,824
| -65% | -$3.53M |
|
823
Arch Capital
ACGL
$34.1B
| $1.93M | 0.01% |
+20,025
| New | +$1.93M |
|
824
OppFi
OPFI
$292M
| $1.92M | 0.01% |
206,508
-69,823
| -25% | -$649K |
|
825
Celestica
CLS
$28.3B
| $1.91M | 0.01% |
+24,211
| New | +$1.91M |
|